Abstract
Objective To explore the factors affecting the early neurological deterioration (END) and short-term prognosis of patients with acute ischemic stroke (AIS) after intravenous thrombolysis. Methods The clinical data of 212 patients with AIS who received intravenous thrombolysis in our hospital from July 2017 to November 2020 were selected and divided into the END group (n = 71) and the non-END group (n = 141) according to the National Institute of Health Stroke Scale (NIHSS) score and divided into the poor prognosis group (n = 85) and the good prognosis group (n = 127) according to the modified Rankin scale (mRS) score at discharge. The basic data of patients, vascular risk factors, imaging examinations, and laboratory indicators were collected. A logistic regression model was used to analyze the influencing factors of END and the short-term prognosis of AIS patients after intravenous thrombolysis. Results Univariate analysis showed that the patient's age, time from onset to treatment (OTT), NIHSS score, diabetes, hypertension, atrial fibrillation, TOAST classification, infarct size, carotid artery stenosis, white blood cell count (WBC), C-reactive protein (CRP), and D-dimer (DD) were associated with END (P < 0.05). Multiple logistic regression analysis found that NIHSS score, diabetes, atrial fibrillation, infarct size, carotid stenosis, and CRP were independent influencing factors of END after intravenous thrombolysis in AIS patients (P < 0.05). Univariate analysis showed that the patient's age, OTT, NIHSS score, diabetes, hypertension, atrial fibrillation, infarct size, carotid stenosis, and the occurrence of END were all related to the short-term prognosis of AIS patients (P < 0.05). Multiple logistic regression analysis showed that age, NIHSS score, infarct size, carotid artery stenosis, and the occurrence of END were all independent factors affecting the short-term prognosis of AIS patients. Conclusion High NIHSS score, combined with diabetes, atrial fibrillation, moderate to severe carotid stenosis, and elevated CRP are all risk factors for END after intravenous thrombolysis in AIS patients. Moreover, advanced age, high NIHSS score, moderate to severe carotid stenosis, and occurrence of END are risk factors for poor short-term prognosis after intravenous thrombolysis in AIS patients.
Highlights
Acute ischemic stroke (AIS) is a group of clinical syndromes in which cerebrovascular stenosis or occlusion leads to the cerebrovascular blood supply, followed by brain damage, necrosis of nerve cells, and neurological dysfunction
Most post-onset AIS patients tend to get better after systemic treatment, there are still some cases where the improvement is not ideal, and symptoms of progressive deterioration of neurological function appear, that is, early neurologic deterioration (END) [3]. e etiology and pathogenesis of END are complicated
If the influencing factors of END in AIS patients can be accurately assessed, and effective prevention and treatment can be carried out at the same time, it will be of great significance to reduce the disability and fatality rate of AIS [5]. is study conducted a retrospective analysis of AIS patients treated with intravenous thrombolysis and explored the impact of related factors on the occurrence of END and short-term prognosis in AIS patients after intravenous thrombolysis
Summary
Acute ischemic stroke (AIS) is a group of clinical syndromes in which cerebrovascular stenosis or occlusion leads to the cerebrovascular blood supply, followed by brain damage, necrosis of nerve cells, and neurological dysfunction. It is a common clinical cerebrovascular syndrome, with a significantly high rate of disability and fatality [1]. Evidence-Based Complementary and Alternative Medicine of AIS has remained high It has become one of the most common causes of disability and death among Chinese adults, threatening the lives of patients [2]. If the influencing factors of END in AIS patients can be accurately assessed, and effective prevention and treatment can be carried out at the same time, it will be of great significance to reduce the disability and fatality rate of AIS [5]. is study conducted a retrospective analysis of AIS patients treated with intravenous thrombolysis and explored the impact of related factors on the occurrence of END and short-term prognosis in AIS patients after intravenous thrombolysis
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Evidence-Based Complementary and Alternative Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
